Logo Logo
Hilfe
Kontakt
Switch language to English
Mammakarzinom - Adjuvante Mitbestrahlung der Lymphabflussgebiete nach Mastektomie oder Brusterhaltender Operation. Wirksamkeit und Verträglichkeit
Mammakarzinom - Adjuvante Mitbestrahlung der Lymphabflussgebiete nach Mastektomie oder Brusterhaltender Operation. Wirksamkeit und Verträglichkeit
Data from 264 patients with surgically treated breast cancer were retrospectively analysed with regard to the treatment effect of extending the adjuvant radiotherapy to include the axillary, intrammamarian, or supraclavicular lymph nodes. The rate of nodal recurrence was 2,7% after extended therapy and 0,8% after local therapy alone. Relapse-free survival was significantly longer after local therapy alone that after extended therapy. The only significant factor in the Cox model was T-status, which dominated over the treatment effect.
breast cancer, radiotherapy, lymph nodes, adjuvant,
Jensen, Eva Elstrup
2005
Deutsch
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Jensen, Eva Elstrup (2005): Mammakarzinom - Adjuvante Mitbestrahlung der Lymphabflussgebiete nach Mastektomie oder Brusterhaltender Operation: Wirksamkeit und Verträglichkeit. Dissertation, LMU München: Medizinische Fakultät
[thumbnail of Jensen_Eva_Elstrup.pdf]
Vorschau
PDF
Jensen_Eva_Elstrup.pdf

519kB

Abstract

Data from 264 patients with surgically treated breast cancer were retrospectively analysed with regard to the treatment effect of extending the adjuvant radiotherapy to include the axillary, intrammamarian, or supraclavicular lymph nodes. The rate of nodal recurrence was 2,7% after extended therapy and 0,8% after local therapy alone. Relapse-free survival was significantly longer after local therapy alone that after extended therapy. The only significant factor in the Cox model was T-status, which dominated over the treatment effect.